Fundraising September 15, 2024 – October 1, 2024 About fundraising

Phase I Study of MEDI3617, a Selective Angiopoietin-2...

  • Main
  • 2018 / 03
  • Phase I Study of MEDI3617, a Selective Angiopoietin-2...

Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined With Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors

Hyman, David M., Rizvi, Naiyer A., Natale, Ronald B., Armstrong, Deborah K., Birrer, Michael J, Recht, Lawrence, Dotan, Efrat, Makker, Vicky, Kaley, Thomas J, Kuruvilla, Denison, Gribbin, Matthew, McD
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-1775
Date:
March, 2018
File:
PDF, 653 KB
english, 2018
Conversion to is in progress
Conversion to is failed